{"id":25562,"date":"2022-10-09T13:55:11","date_gmt":"2022-10-09T17:55:11","guid":{"rendered":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d\/"},"modified":"2023-01-25T13:03:35","modified_gmt":"2023-01-25T18:03:35","slug":"nadav-brandes-ph-d","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/nadav-brandes-ph-d","title":{"rendered":"Nadav Brandes, PhD"},"content":{"rendered":"\n<p>One of the most important breakthroughs in treating cancer has been the engineering of immune cells to target and fight tumors, known as cancer immunotherapy. However, there are many types of cancer and many patients who do not sufficiently respond to this treatment. An immense research effort is underway to expand the applicability of immunotherapy by genetically engineering the immune cells to be more potent against tumors. Dr. Brandes proposes to facilitate more refined and accurate genetic editing in two important ways. First, he proposes to consider specific mutations within genes that could further enhance their antitumor activity in addition to simply amplifying or removing those genes entirely. Second, he will measure how these genetic alterations affect the immune cells by measuring tens of thousands of molecules in each of the cells, instead of a single measurement used by most contemporary studies. This single measurement simply characterizes cells as more or less potent overall, but does so with respect to an isolated cellular experiment which doesn\u2019t necessarily reflect what happens when the engineered immune cells interact with other cells and the complex environments in the human body. Dr. Brandes expects their richer measurements to allow better prediction of the true antitumor activity, and our fine-grained search of beneficial mutations to arrive at more optimally engineered immune cells, thereby allowing immunotherapy to be applicable to more cancer patients and better treat their disease.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Enhancing cancer immunotherapy through gain-of-function screens integrating deep learning and single-cell genomics<\/h3>\n\n\n\n<p>University of California, San Francisco | All Cancers | 2022 | Jimmie Ye, Ph.D.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>One of the most important breakthroughs in treating cancer has been the engineering of immune cells to target and fight tumors, known as cancer immunotherapy. However, there are many types of cancer [&hellip;]<\/p>\n","protected":false},"featured_media":26650,"template":"","tax_cancer_type":[],"tax_grant_type":[486],"tax_award_year":[479],"tax_institutions":[500],"tax_location_states":[501],"class_list":["post-25562","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"Postdoctoral Fellow","quote":"I am looking to understand how genetic mutations affect immune cells so that they can be optimized for anti-tumor activity.","scientist_last_name":"Brandes","show_on_landing":true,"scientist_publish_until":"20250630"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nadav Brandes, PhD - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nadav Brandes, PhD - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"One of the most important breakthroughs in treating cancer has been the engineering of immune cells to target and fight tumors, known as cancer immunotherapy. However, there are many types of cancer [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-25T18:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png\" \/>\n\t<meta property=\"og:image:width\" content=\"440\" \/>\n\t<meta property=\"og:image:height\" content=\"481\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d\",\"name\":\"Nadav Brandes, PhD - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png\",\"datePublished\":\"2022-10-09T17:55:11+00:00\",\"dateModified\":\"2023-01-25T18:03:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png\",\"width\":440,\"height\":481,\"caption\":\"Nadav Brandes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nadav Brandes, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nadav Brandes, PhD - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d","og_locale":"es_ES","og_type":"article","og_title":"Nadav Brandes, PhD - Cancer Research Institute","og_description":"One of the most important breakthroughs in treating cancer has been the engineering of immune cells to target and fight tumors, known as cancer immunotherapy. However, there are many types of cancer [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d","og_site_name":"Cancer Research Institute","article_modified_time":"2023-01-25T18:03:35+00:00","og_image":[{"width":440,"height":481,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d","name":"Nadav Brandes, PhD - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png","datePublished":"2022-10-09T17:55:11+00:00","dateModified":"2023-01-25T18:03:35+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png","width":440,"height":481,"caption":"Nadav Brandes"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/nadav-brandes-ph-d#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Nadav Brandes, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/10\/5957ed32-07b2-4824-9555-aa6a914709c5.png","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/25562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/26650"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=25562"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=25562"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=25562"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=25562"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=25562"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=25562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}